经导管二尖瓣移植术市场(金额，数量，ASP):各市场区隔规模，占有率，趋势及SWOT分析，法律规章及偿付趋势，手术，2033年前的预测

经导管二尖瓣植入术（TMVI）用于治疗主动脉瘤和夹层。主动脉瘤可发生在胸主动脉（胸主动脉瘤-TAA）和腹主动脉（腹主动脉瘤-AAA）。主动脉瘤是由主动脉壁薄弱引起的，促使主动脉壁大的隆起和薄弱。

本报告提供全球经导管二尖瓣移植术市场相关之详细考察，提供市场上竞争情形，SWOT分析，到2033年前的市场预测，COVID-19影响，地区，各国趋势等资讯。

目录

现在上市的经导管二尖瓣移植术和竞争情形

• 主要产业趋势的洞察
• 经导管二尖瓣移植术的各市场区隔整体市场收益和2015年～2033年的市场展望
• 各市场区隔的手术总数，台数，平均销售价格，市场价值相关详细资料

世界，地区，各国洞察

• 经导管二尖瓣移植术市场SWOT分析
• 经导管二尖瓣移植术市场相关竞争动态的洞察和趋势
• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规状况

Abstract

Transcatheter Mitral Valve Implantation Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Transcatheter Mitral Valve Implantation (TMVI) market for the year 2020 and beyond. Transcatheter Mitral Valve Implantation (TMVI) are used to treat aortic aneurysms and dissections. Aortic aneurysms can occur in both the thoracic aorta (Thoracic Aortic Aneurysms - TAA) and abdominal aorta (Abdominal Aortic Aneurysms - AAA). Aortic aneurysms occur when the walls of the aorta weaken, resulting in a large swelling and weakening of the aortic wall.

Abdominal Transcatheter Mitral Valve Implantation (TMVI) are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. Thoracic Transcatheter Mitral Valve Implantation (TMVI) are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. Leg extensions are additional extensions which are used in conjunction with the stent graft to extend the length of the stent graft.

Each of the covered 27 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Mitral Valve Implantation (TMVI) market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Transcatheter Mitral Valve Implantation (TMVI) market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Transcatheter Mitral Valve Implantation (TMVI) market.
• Competitive dynamics insights and trends provided Transcatheter Mitral Valve Implantation (TMVI) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, Sweden, Switzerland, Austria, Belgium, Finland, Norway, Poland, and Portugal.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Transcatheter Mitral Valve Implantation (TMVI) marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Transcatheter Mitral Valve Implantation market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Transcatheter Mitral Valve Implantation market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Implantation market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Transcatheter Mitral Valve Implantation market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.